3种“鸡尾酒疗法”治疗急性脑梗死的成本-效果分析  

Cost-Effectiveness Analysis of 3 "Cocktail" Therapeutic Regimens for Acute Cerebral Infarction

作　　者：杨文波[1] 迟雁[1] 

机构地区：[1]延边大学医学院附属医院,延吉市133000

出　　处：《中国药房》2008年第23期1763-1764,共2页China Pharmacy

摘　　要：目的:比较3种"鸡尾酒疗法"治疗急性脑梗死的效果及成本。方法:141例急性脑梗死患者按照不同药物治疗方案分为3组,分别给予奥扎格雷钠+桂哌齐特+依达拉奉(A组)、长春西汀+棓丙酯+小牛血去蛋白提取物(B组)、阿魏酸钠+丁咯地尔+肌氨肽苷(C组)治疗14d,进行成本-效果分析。结果:A、B、C组人均治疗总成本分别为5970.67、4865.11、3939.72元,显效率分别为82.98%、63.04%、64.58%,成本-效果比分别为7195.31、7717.50、6100.53。结论:A组方案为较佳方案。OBJECTIVE： To evaluate the cost- effectiveness of 3 ＂Cocktail＂ therapeutic regimens in treating acute cerebral infarction （ACI） . METHODS： 141 patients with ACI were administered with Sodium Ozagrel ＋ Cinepazide ＋ Edaravone （Group A）, Vinpocetine ＋ Propylgallate ＋ Deproteinized calf blood Extractives （Group B） or Sodium Ferulate ＋ Buflomedil ＋ Muscular Amino Acids and Peptides and Nucleosides （Group C） for 14d. Cost - effectiveness analysis in pharmacoeconomics was applied to analyze the therapeutic effects and costs. RESULTS： The total costs of 3 groups （A, B and C） were 5 970.67 yuan, 4 865.11 yuan and 3 939.72 yuan, respectively, the efficiency rates were 82.98%, 63.04% and 64.58% respectively, and the cost - effectiveness ratio were 7 195.31, 7 717.50 and 6 100.53, respectively. CONCLUSION： Group A is preferable for ACI.

关 键 词：急性脑梗死 鸡尾酒疗法 成本-效果分析 

分 类 号：R972.4[医药卫生—药品] R956[医药卫生—药学]